School of Medicine
Showing 1-50 of 63 Results
-
Daniel Michael Blonigen
Casual - Non-Exempt, Psych/Public Mental Health & Population Sciences
BioDr. Blonigen is an Investigator and an Associate Director at the Center for Innovation to Implementation, VA Palo Alto Health Care System. He is also an Affiliate Investigator with the VA National Center for Homelessness Among Veterans, and a Clinical Associate Professor (Affiliated) in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine. He received his doctorate in clinical psychology from the University of Minnesota and is a former VA Career Development Awardee in Clinical Sciences R&D. He is licensed as a clinical psychologist in the State of California.
Dr. Blonigen’s research mission is to identify and develop innovations to increase access and engagement in substance use and mental health care for vulnerable populations. In particular, he is interested in testing the effectiveness and implementation potential of mobile health and peer-based interventions for justice-involved and homeless veterans. He is currently leading or co-leading multisite trials of behavioral interventions for justice-involved and homeless veterans. He is also funded by VA HSR&D to tailor smartphone applications for self-management of unhealthy drinking for veteran primary care patients and use of peer specialists to increase patient engagement with these apps.
In addition to research, Dr. Blonigen is actively involved in mentoring and teaching VA research fellows and Stanford University residents. These roles include serving as a faculty mentor for the Stanford Forensic Psychiatry Fellowship Program, as well as directing the research training program for clinical psychology interns at VA Palo Alto. He is a member of several VA management and oversight committees and has served as a grant reviewer for national and international funders. He is an invited speaker at national conferences and cyberseminars devoted to substance use and mental health research, and he holds editorial positions for leading addiction, personality, and assessment journals. -
Steven Chan, MD MBA
Clinical Assistant Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioSteven Chan (@StevenChanMD, StevenChanMD.com ), is a clinical informaticist and addiction physician at Palo Alto VA Health, affiliated with Stanford University School of Medicine. Dr. Chan is co-investigator on clinical research — at UC Davis, funded by the U.S. Department of Health & Human Services; and at UCSF, funded by the Stanford-UCSF Center for Excellence in Regulatory Sciences — in areas of telehealth and digital health. Dr. Chan is a sought-after national speaker whose ideas, thoughts, and research have been featured at Fortune 50 companies such as Google; publications such as JAMA, Telemedicine and e-Health, JMIR (Journal of Medical Internet Research), U.S. News & World Report, and Wired; and on media outlets including the Washington Post, Wired, PBS and NPR Ideastream. Dr. Chan served as Vice Chair for the Workgroup on Mental Health & Psychiatric Apps at the American Psychiatric Association (APA), and serves on the Committees on Innovation, Telepsychiatry, and Mental Health Information Technology.
Dr. Chan additionally serves as Founder & CEO of MentalPowerHacks.com, media education for life hacks for performance, productivity & success.
Dr. Chan draws from his extensive medical, business, and informatics training at California’s leading institutes — UC Berkeley, UC Irvine, UC Davis, as well as UCLA, UC San Francisco and Stanford University -
Helene Chokron Garneau
Sr Res Scholar, Psych/Public Mental Health & Population Sciences
Current Role at StanfordSenior Research Scientist
-
David Eagleman
Adjunct Professor, Psych/Public Mental Health & Population Sciences
BioDavid Eagleman is a neuroscientist, bestselling author, and Guggenheim Fellow. Dr. Eagleman’s areas of research include sensory substitution, time perception, vision, and synesthesia. He also studies the intersection of neuroscience with the legal system, and in that capacity he directs the non-profit Center for Science and Law. Eagleman is the writer and presenter of The Brain, an Emmy-nominated television series on PBS and BBC. He is the author of 8 books, including Livewired, The Runaway Species, The Brain, Incognito, and Wednesday is Indigo Blue. He is also the author of a widely adopted textbook on cognitive neuroscience, Brain and Behavior. His internationally bestselling book of literary fiction, SUM, has been translated into 32 languages, turned into two operas, and named a Best Book of the Year by Barnes and Noble. Dr. Eagleman has been a TED speaker, a guest on the Colbert Report, and profiled in the New Yorker magazine. He has launched several neuroscience companies from his research, including Neosensory and BrainCheck.
-
William O Faustman
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Faustman received his doctorate in clinical psychology from the University of Mississippi and completed his internship at the VA Palo Alto Health Care System. He has an active interest in training, administration, forensic practice, and clinical care in inpatient psychiatry. His research interests have focused on severe mental illness with an emphasis in areas such as cognition and clinical assessment.. He serves as a member of the Stanford IRB and coordinates the American Psychological Association accredited postdoctoral fellowship program at the VA Palo Alto. He holds Chartered Psychologist status with the British Psychological Society,
-
Howard H Fenn MD
Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
BioCurrent CV available on request to
hhfenn@aol.com
CLINICAL:
Inpatient psychiatry attending at VA HCS Palo Alto for over 30 years.
Medical Director, Geriatric Psychiatry unit, VA HCSC Palo Alto/Menlo Park for 10 years
Outpatient psychiatrist at Palo Alto Medical foundation/Sutter for 15 years
CURRENT PUBLICATIONS:
Lead Editor, Inpatient Geriatric Psychiatry, Springer, 2019
LEGAL/FORENSIC:
Consultation practice on legal issues and court testimony for >40 years
Expert consultant/witness for Coleman vs. California Department of Corrections for 4 years
Qualified Medical Examiner (QME) for Division of Worker's Compensation for 15 years
Compensation and Pension Unit, VA HCS Palo Alto for 5 years
SEMINAR LEADER:
Psychiatric Issues in Cognitive Impairment -- Stanford/VA Alzheimer's Center (SVAAC)
Legal Aspects of Geriatric Psychiatry (Stanford/VA Geriatric Psychiatry Fellowship
Didactic topics on inpatient psychiatry rotation for Stanford Geriatric Psychiatry fellows
EDUCATIONAL/ADMINISTRATIVE:
Program Director, Stanford/VA Geriatric Psychiatry Fellowship, 3 years
Site Director, Inpatient Psychiatry Rotation/Geriatric Medicine Fellowship --6 years
SCHOLARSHIP:
Lead Editor of textbook, Inpatient Geriatric Psychiatry, published by Springer in 2019.
Slide presentations published by the American Society of Clinical Pharmacology (ASCP), editor Ira Glick, MD, entitled:
--Pharmacological Treatment of PTSD
--Behavioral and Psychological symptoms of Dementia
Chapters, review articles on topics of Medication management for Major Neurocognitive Disorder with Behavioral Disturbance
Chapter in Inpatient Geriatric Psychiatry, in On-Call Geriatric Psychiatry (2016), Springer.
. -
Becky Fullmer
Administrative Associate 3, Psych/Public Mental Health & Population Sciences
Current Role at StanfordBecky provides administrative support to Dr. Carolyn Rodriguez and the Rodriguez Lab within the School of Medicine's Psychiatry and Behavioral Sciences Department.
-
Ansgar Furst
Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesBioDr. Furst is a Clinical Associate Professor (affiliated) of Psychiatry and Behavioral Sciences and of Neurology and Neurological Sciences at Stanford University School of Medicine. He is a Principal Investigator and Director of the California War Related Illness and Injury Study Center (WRIISC) Advanced Fellowship Post-Doctoral program and Associate Director of Neuroimaging. He is also a Senior Research Scientist at the Polytrauma System of Care (PSC) at VA Palo Alto Health Care System. Dr. Furst serves as Associate Editor for the journal Frontiers in Neurology and is a member of the editorial board of NEUROLOGY. His research focuses on diagnostics and interventions related to traumatic brain injury, sleep, pain and Alzheimer's disease.
For more information please visit:
https://med.stanford.edu/furstlab.html -
Jessica E. Gonzalez
Soc Science Rsch Prof 3, Psych/Public Mental Health & Population Sciences
BioJessica E. Gonzalez, MSW is the Associate Project Director for the Mental Health Technology Transfer Center (MHTTC) Network Coordinating Office (NCO). The MHTTC NCO is part of the Center for Behavioral Health Services and Implementation Research (CBHSIR) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Through the MHTTC School Mental Health Initiative, Jessica is coordinating the work of 12 centers that provide training and technical assistance to the mental health and school mental health workforce to increase the use of evidence-based mental health prevention, treatment, and recovery support services for students across the United States.
Jessica has worked in the community as a social worker providing mental health services in school and outpatient clinic settings to children and adolescents of diverse socioeconomic, cultural and ethnic backgrounds. In addition, she has over 5 years of experience in project management support and coordination for research and evaluation in the areas of early childhood learning and development, special education, post-secondary education attainment, and delivery of school mental health services. Jessica has also worked for several high school and college programs in the area seeking to improve educational outcomes for first-generation and low-income students of color. -
Michelle Madore, Ph.D.
Staff, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Clinical Assistant Professor (Affiliated), Psych/Public Mental Health & Population SciencesBioDr. Madore is multiracial, Filipina woman working as a Clinical Neuropsychologist at VA Palo Alto Healthcare System (VAPAHCS) in the Mental Illness Research, Education and Clinical Center (MIRECC). Here she serves as the Director of the National Clinical Transcranial Magnetic Stimulation (TMS) Program whose mission is to: 1) increase the availability of Transcranial Magnetic Stimulation (TMS) for treatment-resistant depression in Veterans and (2) gain a greater understanding of the treatment efficacy of TMS in our complex Veteran population. She is also the Co-Director of the Sierra Pacific MIRECC Advanced Fellowship at VAPAHCS. Dr. Madore is the site PI on two multi-site funded studies looking at neuroimaging biomarkers of treatment response to TMS in treatment-resistant depression. Dr. Madore is also a Clinical Assistant Professor (Affiliated) at Stanford University School of Medicine’s Department in Psychiatry and Behavioral Sciences.
She received her Ph.D. in clinical psychology from the University of Cincinnati, where she received specialized training in neuropsychology. Dr. Madore completed her pre-doctoral internship at the VA Palo Alto Health Care System (VAPAHCS). She has completed postdoctoral training focused on clinical neuropsychology and neurorehabilitation research at VA Martinez, San Francisco VA Medical Center and VAPAHCS.
Dr. Madore is involved in several professional organizations and serves in several leadership positions. She is the Chair of the Public Interest Advisory Committee for the Society of Clinical Neuropsychology, a Co-Finance Officer for the Asian American Psychological Association, and Treasurer for the Asian Neuropsychological Association. -
Pavithra Mukunda
Lab Manager, Psych/Public Mental Health & Population Sciences
Current Role at StanfordAssistant Clinical Research Coordinator
-
Martin Stefan Mumenthaler
Adjunct Professor, Psych/Public Mental Health & Population Sciences
BioMartin Mumenthaler has a PharmD and a PhD in psychopharmacology from the University of Bern, Switzerland. He holds an appointment as Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has been conducting research programs in addiction medicine and psychopharmacology, and teaching and mentoring medical students and residents on a voluntary basis.
Dr. Mumenthaler has also been working in various full-time positions in the pharmaceutical industry as Director in Clinical Development as well as in Medical Affairs, and as a consultant for early-stage pharma- and biotech companies providing advice on designing and conducting clinical trials, and analyzing and interpreting study results, mainly in the field of addiction medicine and pain.
His academic research has focused on the effects of psychoactive drugs on human performance, Aerospace Medicine, Alzheimer’s disease, and addiction medicine, and in these areas he has presented his results internationally and published over twenty-five peer-reviewed scientific articles. He has also served as a reviewer for various scientific journals, and is a member of the Research Society on Alcoholism, and an Associate Fellow of the Aerospace Medical Association. -
Allyson Rosen, Ph.D., ABPP-CN
Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioRESEARCH FOCUS
Translational cognitive neuroscience of aging and dementia. Neuroethics.
TRAINING
Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.
CLINICAL AND RESEARCH ACTIVITIES
Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford’s Alzheimer’s Disease Research Center (NIA). Dr. Rosen’s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.
ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
Ethics Review
http://www.j-alz.com/blogs/discussion/protecting-progress
MIRECC DEMENTIA EDUCATION
http://www.mirecc.va.gov/visn21/education/dementia_education.asp -
Blake K. Scanlon, Ph.D.
Adjunct Lecturer, Psych/Public Mental Health & Population Sciences
BioThe overarching aim of Dr. Scanlon’s research is to develop and evaluate low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. To that end, the Caregiver Technology Division of the Scanlon Lab aims to enhance patient- and family-centered care through novel, broadly customizable, and highly scalable caregiver interventions. In parallel, the Neurodegenerative Division of the Scanlon Lab focuses on the development and application of cognitive, neuropsychiatric, and biological markers for the initiation and progression of neurodegeneration.
Dr. Scanlon received his bachelor’s degree in Neuroscience and doctorate in Clinical Health Psychology from the University of Miami. After concluding his clinical internship in Geropsychology/Neuropsychology at the VA Palo Alto Health Care System (VAPAHCS), he completed fellowships in Aging and Dementia at Stanford University School of Medicine and VAPAHCS. Dr. Scanlon is currently a VA Career Development Awardee in the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC) and Stanford/VA Aging Clinical Research Center where his work focuses on developing and evaluating low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. He also serves as Co-Director of the Stanford/VA California Alzheimer's Disease Center, Chair of the VAPAHCS Dementia Committee, and Co-Chair of the Department of Veterans Affairs VISN 21 Dementia Committee. -
Logan Schneider
Clinical Assistant Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesCurrent Research and Scholarly InterestsFrom a research perspective, my long-term career plan is to refine the understanding of normal and dysfunctional sleep, much like the Epilepsy Phenome/Genome Project (EPGP) and Epi4K are doing for the enigmatic epilepsies. Insufficient sleep has been deemed a public health problem with poorly understood behavioral and physiologic sleep disorders lying at the core of the issue. I am currently using well-defined distinct and objective phenotypes (e.g. periodic limb movements, hypocretin-deficient narcolepsy) to acquire the analytic skills necessary to expand my knowledge of both signal processing and genetics, with the former enhancing my ability to identify and/or refine sleep phenotypes, and the latter facilitating the pathophysiological understanding of these phenotypes. As a consequence of a better link between symptoms/phenotypes, physiology, and genetic risks, more personally targeted and effective therapeutics can be developed to address the enriched spectrum of sleep disorders.
